Metabolic & Weight Research
AOD-9604 10mg
AOD-9604 10mg
Isolate the metabolic questions within the GH fragment.
A synthetic growth-hormone fragment explored in preclinical lipid-metabolism research, including lipolysis and lipogenesis signalling.
- Documentation
- Check batch record
- Availability
- In stock
For qualified laboratory research only · Not for human or veterinary use
Why researchers choose it
AOD-9604 is derived from the C-terminal region of human growth hormone and was developed to examine fat-cell signalling without using the full growth-hormone molecule.
Research focus
- Adipocyte and lipid-metabolism models
- Lipolysis and lipogenesis signalling
- Growth-hormone-fragment pharmacology
Evidence snapshot
Preclinical models generated the core metabolic rationale. Human obesity development did not establish a reliable therapeutic benefit, so this listing makes no fat-loss claim.
Best suited to
For mechanistic metabolic research where model, exposure and lipid endpoints are explicitly defined.
Research focus describes published study domains, not a guaranteed outcome. No human or veterinary dosing, reconstitution or administration instructions are supplied.
Related research compounds
Metabolic & Weight10mg
A supplier-named formulation reserved for composition, identity and formulation research; exact ingredients must be established from the matching lot record.
Metabolic & Weight15mg
Triple-pathway research across GIP, GLP-1 and glucagon signalling—the combination driving next-generation interest in appetite, glucose and energy expenditure.
Metabolic & Weight10mg
Dual-pathway metabolic research built around GIP and GLP-1 signalling, with established relevance to appetite, glucose and energy-balance pathways.